• Zenan Wu, Guixing Xu, Jun Xiong, Zhengyun Zuo, Xinyu Yu, and Qiongshan Xie.
• Jiangxi University of Traditional Chinese Medicine, Nanchang.
• Medicine (Baltimore). 2020 Nov 13; 99 (46): e22342.

BackgroundMyofascial pain syndrome (MPS) is a chronic systemic pain disorder. Among the common treatments, moxibustion has an irreplaceable therapeutic effect and is an effective Traditional Chinese Medicine therapy for MPS. However, the lack of clinical practice guidelines (CPGs) has prompted the publication of guidelines on the use of moxibustion in the treatment of MPS.MethodsThe clinical practice guideline will base on the Institute of Medicine, the World Health Organization guideline handbook, the Grade of Recommendations Assessment, Development, and Evaluation the Appraisal of Guidelines for Research & Evaluation II, Reporting Items for practice, Guideline in Healthcare and recommendations thereof will be made on the basis of systematic reviews. We will establish a guidelines development team that will draft clinical questions in the form of population, intervention, comparison, results and conduct a literature search and quality of evidence assessment. The experts will make recommendations after 2 or 3 rounds of Delphi investigations. We will carefully consider the patient's values and preferences and conduct a peer review.Ethics And DisseminationThe guidelines will not contain any personal data and will not prejudice individual rights, so no ethical approval will be required. The guidelines will be subject to rigorous peer review and may be published in a journal or circulated at relevant conferences.ResultsThe guidelines will be published in relevant peer-reviewed journals.ConclusionThis guideline will make it easier for clinicians to treat MPs in the clinical setting and improve the effectiveness of treatment for MPS.Study RegistrationThe study is registered with the International Practice Guideline Registry Platform (IPGRP): IPGRP-2020CN030.

21 keywords...

hide…